Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) was up 3.7% during trading on Wednesday . The stock traded as high as $1.36 and last traded at $1.20. Approximately 662,257 shares changed hands during trading, an increase of 30% from the average daily volume of 509,028 shares. The stock had previously closed at $1.25.

Separately, Zacks Investment Research cut shares of Ekso Bionics Holdings from a “buy” rating to a “hold” rating in a research report on Tuesday, July 11th.

In related news, insider Russ Angold sold 28,254 shares of the firm’s stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $1.53, for a total value of $43,228.62. Following the completion of the transaction, the insider now owns 250,678 shares in the company, valued at approximately $383,537.34. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In the last quarter, insiders purchased 41,264 shares of company stock valued at $48,255 and sold 259,352 shares valued at $399,373. 7.10% of the stock is owned by company insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. raised its holdings in Ekso Bionics Holdings by 32.9% in the 2nd quarter. Vanguard Group Inc. now owns 711,082 shares of the company’s stock valued at $1,650,000 after buying an additional 176,197 shares during the last quarter. National Planning Corp raised its holdings in Ekso Bionics Holdings by 116.2% in the 2nd quarter. National Planning Corp now owns 234,450 shares of the company’s stock valued at $537,000 after buying an additional 126,000 shares during the last quarter. Intellectus Partners LLC raised its holdings in Ekso Bionics Holdings by 5.3% in the 2nd quarter. Intellectus Partners LLC now owns 105,294 shares of the company’s stock valued at $244,000 after buying an additional 5,294 shares during the last quarter. Carl Domino Inc raised its holdings in Ekso Bionics Holdings by 74.7% in the 2nd quarter. Carl Domino Inc now owns 82,054 shares of the company’s stock valued at $190,000 after buying an additional 35,088 shares during the last quarter. Finally, Independence Advisors LLC bought a new position in Ekso Bionics Holdings in the 2nd quarter valued at approximately $1,840,000. Institutional investors and hedge funds own 6.04% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Ekso Bionics Holdings, Inc. (EKSO) Trading Up -3.7%” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/10/13/ekso-bionics-holdings-inc-ekso-trading-up-3-7.html.

Ekso Bionics Holdings Company Profile

Ekso Bionics Holdings, Inc designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness.

Receive News & Stock Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related stocks with our FREE daily email newsletter.